MedPath

Evaluation of Corneal Endothelial Changes After Uneventful Phacoemulsification in Diabetic and Non-diabetic Patients in Relation to the Level of Glcosylated Hemoglobin Level

Not Applicable
Conditions
Corneal Endothelial Changes After Phacoemulsification
Interventions
Device: Specular biomicroscopy
Registration Number
NCT05426590
Lead Sponsor
Marwa Ahmed
Brief Summary

Evaluation of corneal endothelial changes after uneventful phacoemulsification in diabetic and non-diabetic patients using specular biomicroscopy in relation to the level of glcosylated hemoglobin level

Detailed Description

86 patients will be divided into two equal groups of diabetic and non-diabetic patients will undergo phacoemulsification of cataract will be evaluated thier endocelium before surgery and 3 weeks after surgery to detect the effect of level of glcosylated hemoglobin on the endothelial changes after uneventful phacoemulsification

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Diabetics and non-diabetic patients undergo cataract surgery
  • Age between 50-60 years old
  • Corrected distance visual acuity<0.4
  • Gender: both genders.
Exclusion Criteria
  • Chronic Ocular diseases (glaucoma,uveitis, amblyopia, strabismus,keratoconus, corneal opacity).
  • corneal dystrophy History of previous keratitis or viral corneal infection. Corneal dystrophy Ocular trauma. Previous ocular surgery. Complicated cataract surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diabetic patientSpecular biomicroscopyPatient with diabetes will undergo cataract surgery
Non diabetic patientsSpecular biomicroscopyHealthy non diabetic patients will undergo cataract surgery
Primary Outcome Measures
NameTimeMethod
Defferentiate patients into diabetic and non-diabetic patients according to the endothelial changes after uneventful phacoemulsification6 monthes

Detect effect of glycosylated hemoglobin level after uneventful phacoemulsification in diabetic and non-diabetic patients

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath